S1 Ep7: Hoping for Something Better: Real World Evidence Part 2

Real world evidence is a powerful tool that can be used to provide insights on diseases, medicines, patient populations, and healthcare practices. RWE also plays a very important role in drug discovery and is used by the FDA and the pharmaceutical industry. A key strategic priority of the FDA is to leverage real world evidence in order to improve regulatory decisions. On this episode, Joe talks to Brande Yaist, Sr. Director of Global Patient Outcomes and RWE at Lilly about why getting it right is so important. Joe also talks to Dr. Adrian Hernandez, vice dean of clinical research at Duke University about an exciting new project with Google called Project Baseline and why he is hopeful that the collection of RWE in this new digital era will allow us to be more forward thinking about future health problems.